706792-04-3 Usage
Uses
Used in Pharmaceutical Industry:
Benzoic acid, 3-amino-5-ethoxy-, methyl ester (9CI) is used as an intermediate compound for the synthesis of various pharmaceutical products. Its unique structure allows it to be a key component in the development of new drugs, particularly those targeting specific biological pathways or receptors.
Used in Chemical Research:
In the field of chemical research, Benzoic acid, 3-amino-5-ethoxy-, methyl ester (9CI) is used as a model compound to study the properties and reactions of esters and amines. Its structure provides insights into the behavior of similar compounds and can be used to develop new synthetic methods or understand the mechanisms of certain chemical reactions.
Used in Material Science:
Benzoic acid, 3-amino-5-ethoxy-, methyl ester (9CI) is used as a building block in the development of new materials with specific properties. Its unique chemical structure can be incorporated into polymers or other materials to impart desired characteristics, such as improved stability, reactivity, or biocompatibility.
Used in Agricultural Industry:
In the agricultural industry, Benzoic acid, 3-amino-5-ethoxy-, methyl ester (9CI) may be used as a component in the formulation of pesticides or other agrochemicals. Its chemical properties can be harnessed to enhance the effectiveness of these products or to improve their environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 706792-04-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,6,7,9 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 706792-04:
(8*7)+(7*0)+(6*6)+(5*7)+(4*9)+(3*2)+(2*0)+(1*4)=173
173 % 10 = 3
So 706792-04-3 is a valid CAS Registry Number.
706792-04-3Relevant academic research and scientific papers
CRYSTALLINE FORMS OF TRICYCLIC COMPOUND ACID SALT OR HYDRATE THEREOF, AND METHOD FOR MAKING THEREOF
-
, (2014/12/09)
The present invention relates to a novel crystalline acid salt of a tricyclic derivative or a hydrate thereof and a production method thereof. The crystalline acid salt or the hydrate thereof according to the present invention is stable with respect to hu
HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page 30, (2010/02/07)
The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.
ASPARTYL PROTEASE INHIBITORS
-
Page 204-208, (2010/02/05)
The present invention provides compounds having formula (I): wherein R’, R0, R1, X1, R2, R3, R3’, X2, X3, and R4 are as defined herein, and pharmaceuticals compositions thereof. The present invention also provides methods of inhibiting proteases, more specially aspartyl proteases. In certain embodiments, compounds inhibit BACE (β-site APP-cleaving enzyme), and thus are useful in the treatment or prevention of a disease characterized by β-amyloid deposits in the brain (including, but not limited to, Alzheimer’s Disease). The present invention also provides methods for preparing compounds of the invention.
